Andrew Hall

Andrew Hall is from Gillette, New Jersey, United States. Andrew works in the following industries: "Pharmaceutical Manufacturing". Andrew is currently Chief Executive Officer at IMV Inc.. Andrew also works as Interim Chief Executive Officer at IMV Inc., a job Andrew has held since Aug 2021. Another title Andrew currently holds is Chief Business Officer at IMV Inc.. In Andrew's previous role as a Exec Director, BD and Global Alliances at Celgene, Andrew worked in until Dec 2019. Prior to joining Celgene, Andrew was a Executive Director - Immunology and Inflammation at Celgene and held the position of Executive Director - Immunology and Inflammation at new york. Prior to that, Andrew was a Global New Products Leader - Women's Health at Merck, based in United States from Feb 2012 to Apr 2014. Andrew started working as Franchise Leader New Products at Merck in Mar 2010. From Jan 2007 to Oct 2010, Andrew was Director Asia Pacific at Schering-Plough. Prior to that, Andrew was a Marketing Manager Australia and NZ at Schering-Plough from Jan 2005 to Jan 2007. Andrew started working as product manager at BMS in Jan 2004.